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This study was to investigate the quinolones resistance to gram-positive cocci isolated in the First Bethune Hospital 
during the past 8 years. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed by 
WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). The rates of 
methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococci 
(MRCNS) were 50.8 ~83.3  and 79.4 ~81.5  during the past 8 years, respectively. In recent 8 years, the 
quinolones resistance to gram-positive cocci had increased. Monitoring of the quinolones resistance to gram-positive 
cocci should be strengthened. The change of the antimicrobial resistance should be investigated in order to guide 
rational drug usage in the clinic and prevent bacterial strain of drug resistance from being transmitted. 
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1.Introduction 
High prevalences of quinolones resistance in gram-positive cocci have been described in America and 
Asia [1-3]. In Staphylococcus aureus and coagulase-negative Staphylococci, quinolones resistance has 
been more frequently found among methicillin-resistant Staphylococci spp strains than among 
methicillin-sensitive Staphylococci spp strains, which may be related to the mecA-mediated resistance. 
The objectives of this study were to investigate the quinolones resistance to gram-positive cocci in 8 
consecutive years in the First Bethune Hospital. 
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2.Materials and methods 
2.1.Bacterial isolates 
Consecutive nonduplicate nosocomial isolates of gram-positive cocci were collected during the 
period from 2003 to 2010 in the First Bethune Hospital. Isolates were identified at the species level using 
standard biochemical tests and microbiological methods. 
2.2.Antimicrobial susceptibility testing 
Antimicrobial susceptibility testing. The susceptibilities of gram-positive cocci to 3 quinolones agents 
were determined by the disk diffusion method in accordance with CLSI guidelines. 
2.3.Detection of MRSA and MRCNS production  
Detection of MRSA and MRCNS production was according to CLSI. Staphylococcus aureus ATCC 
25923 and Staphylococcus aureus ATCC 43300 strains served as quality controls.  
3.Results 
The rates of MRSA were 50.8% (31/61), 58.0% (40/69), 60% (48/80), 79.8% (79/99), 83.3% 
(100/120), 80.8% (295/365), 81.3% (260/320), 80.3.% (285/355) from 2003 to 2010, respectively. The 
rates of MRCNS were 80.0% (164/205), 80.4% (181/225), 80.3% (196/244), 80.7% (180/223), 81.5% 
(220/270), 79.4% (269/339), 80.2% (380/474), 81.3% (410/504) from 2003 to 2010, respectively. 
The resistance of MRSA, MRSCN, Enterococcus faecalis, Enterococcus faecium to ciprofloxacin 
was more than 50%, however, the resistance of MSSA and MSCNS to ciprofloxacin was no more than 
30% during the past 8 years. Overall, the resistance of MRSA, MRSCN, Enterococcus faecalis, 
Enterococcus faecium to levofloxacin and gatifloxacin was more than 40%, however, the resistance of 
MSSA and MSCNS to levofloxacin and gatifloxacin was no more than 25% during the past 8 years. In 
recent 8 years, the quinolones resistance to gram-positive cocci had increased. 
The resistance of gram-positive cocci to quinolones is shown in table 1  
4.Discussion 
The current study showed prevalence of MRSA and MRCNS range from 50.8 ~83.3  to 
79.4%~81.5% in Staphylococcus aureus and coagulase-negative Staphylococci in the First Bethune 
Hospital, respectively. The resistance rates of methicillin-resistant Staphylococci spp to quinolones were 
much higher than those of methicillin- sensitive Staphylococci spp in 8 consecutive years in the First 
Bethune Hospital. Our study showed the resistance rates of Enterococcus faecalis and Enterococcus 
faecium to quinolones were also very high. 
Three mechanisms of resistance to quinolones are currently recognized: mutations that alter the drug 
targets, mutations that reduce drug accumulation, and plasmids that protect cells from the lethal effects of 
quinolones. Broad use of quinolones has been followed by emergence of resistance, which has been due 
mainly to chromosomal mutations in genes encoding the subunits of the drugV target enzymes, DNA 
gyrase and topoisomerase IV, and in genes that affect the expression of diffusion channels in the outer 
membrane and multidrug-resistance efflux systems. Recently, qnr genes, aac(6 )-Ib-cr gene, quinolones 
efflux pump protein QepA have involved. In Staphylococcus aureus, resistance to quinolones is 
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associated with increased expression of norA, a gene that encodes a broad-spectrum transporter for 
quinolones and other agents. It is alerted that too much quinolone have been used in China. 
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, 
cut costs and delay the emergence of resistant organisms. 
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TABLE 1   Resistance of gram-positive cocci to quinolones ( ) 
 
*CIP: 
ciprofloxacin, LEV: levofloxacin, GAT: gatifloxacin, MSSA: methicillin-sensitive Staphylococcus aureus, MRSA: 
methicillin-resistant Staphylococcus aureus, MSCNS: methicillin-sensitive coagulase-negative Staphylococci, MRCNS: 
methicillin-resistant coagulase-negative Staphylococci 
cocci year isolates CIP LEV GAT cocci year isolates CIP LEV GAT 
MSSA 2003 30 6.7 6.7 3.3 MRCNS 2003 164 61.6 42.3 18.3 
 2004 29 6.7 6.9 3.4  2004 181 60.2 40.3 20.4 
 2005 32 12.5 9.4 6.3  2005 196 70.6 43.1 26.8 
 2006 20 15.0 10.0 5.0  2006 180 67.0 48.9 29.4 
 2007 20 15.0 10.0 5.0  2007 220 70.5 50.0 30.5 
 2008 70 25.7 18.6 11.4  2008 269 71.0 53.2 35.3 
 2009 60 23.3 16.7 10.0  2009 380 71.1 53.9 36.1 
 2010 70 24.3 18.6 10.0  2010 410 71.9 54.9 36.6 
MRSA 2003 31 80.6 71.0 32.3 Enterococcus faecalis 2003 61 50.8 47.5 42.6 
 2004 40 87.5 77.5 40.0  2004 79 53.2 51.9 44.3 
 2005 48 91.7 91.7 49.0  2005 80 61.5 59.5 48.8 
 2006 79 98.7 94.9 59.5  2006 65 69.2 55.4 53.8 
 2007 100 98.0 94.0 66.0  2007 91 70.3 58.2 54.9 
 2008 295 98.3 96.6 70.2  2008 154 74.7 64.9 58.4 
 2009 260 98.1 96.2 71.2  2009 145 76.6 65.5 62.1 
 2010 285 98.2 97.2 77.2  2010 175 74.3 68.6 62.9 
MSCNS 2003 41 19.5 12.2 9.8 Enterococcus faecium 2003 43 83.7 81.4 69.8 
 2004 44 20.5 13.6 9.1  2004 45 86.7 84.4 68.9 
 2005 48 22.9 16.7 10.4  2005 42 88.9 85.7 82 
 2006 43 23.3 18.6 11.6  2006 65 87.7 84.6 69.2 
 2007 50 24.0 18.0 12.0  2007 71 91.5 84.5 70.4 
 2008 70 24.3 20.0 15.7  2008 99 90.9 85.9 72.7 
 2009 94 25.5 20.2 14.9  2009 111 91.9 90.1 72.1 
 2010 94 26.6 22.3 16.0  2010 120 91.7 90.8 75.0 
